Researcher Spotlight: Ran Xu, PhD DANA FARBER CANCER INSTITUTE Many patients with mantle cell lymphoma (MCL) achieve complete remission with novel chimeric antigen receptor (CAR) T cell therapies, but some cancer cells remain that may eventually lead to relapse. Using…
Oral Therapy and Adherence in Lymphoma An increasing number of lymphoma and chronic lymphocytic leukemia (CLL) patients receive their chemotherapy not from intravenous (IV) treatments administered in a hospital or clinic, but via a pill, taken at home on a…
Researcher Spotlight: Christina Lee, MD Memorial Sloan Kettering Cancer Center It has become increasingly apparent that normal immune cells are important in disease progression and therapy resistance in lymphoma. Studies from a clinical trial of two targeted therapies, ibrutinib (Imbruvica)…
Researcher Spotlight: Allison Rosenthal, DO Mayo Clinic Arizona Mantle cell lymphoma (MCL) can present in a variety of ways, from slow-growing indolent to more aggressive forms with poorer outcomes. Currently a patient’s treatment plan is largely based on patient age…
Researcher Spotlight: John P. Leonard, MD Weill Cornell Medicine Chemotherapy is an effective strategy in treating many lymphoma patients, however, its toxicity and the growing number of effective novel therapies for lymphoma has prompted researchers to explore chemotherapy-free options…
Researcher Spotlight: Craig Portell, MD University of Virginia Dr. Portell, an Assistant Professor of Medicine at the University of Virginia (UVA), joined UVA’s faculty in order to work with Dr. Michael E. Williams, a Lymphoma Research Foundation (LRF) Scientific…
Researcher Spotlight: Danielle Brander, MD Duke University Dr. Brander is a second year faculty member in the Division of Hematologic Malignancies and Cellular Therapy at Duke University. Her interests as a research clinician are improving and developing novel therapies…
Researcher Spotlight: Jianguo Tao, MD, PhD H. Lee Moffitt Cancer and Research Institute Though available therapies for lymphoma are becoming increasingly effective at slowing disease progression and prompting remissions, many patients eventually develop drug resistance that allows their disease…
Researcher Spotlight: Andre Goy, MD, MS John Theurer Cancer Center Dr. Goy is the Chairman and Director of the John Theurer Cancer Center in Hackensack, NJ, where he is also Chief of the Division of Lymphoma. At John Theurer,…
Researcher Spotlight: Connie Batlevi, MD, PhD Memorial Sloan Kettering Cancer Center Dr. Batlevi’s Lymphoma Clinical Research Mentoring Program (LCRMP) project seeks to capitalize on the success of two classes of novel targeted therapies that have shown effectiveness in lymphoma…